Article
Does the A3333G mutation in the CACNL1A3 gene, detected in malignant hyperthermia, also occur in central core disease?
Genetic testing - 1 Jan 2000
Vainzof M, Muniz V P, Tsanaclis A M, Silva H C, Rusticci M S
Abstract excerpt
Malignant hyperthermia (MH) and central core disease (CCD) are two conditions associated with susceptibility to volatile anesthetics and depolarizing muscle relaxants. The gene RYR1, encoding the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum, is responsible for about 50% of the cases of MH and some cases of CCD. However, genetic heterogeneity occurs in MH and a mutation in a second gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
